91 related articles for article (PubMed ID: 15017863)
1. [Postoperative thromboembolic complications and preventive measures].
Vegar-Brozović V; Prajdić-Predrijevac D
Med Arh; 2003; 57(4 Suppl 1):41-3. PubMed ID: 15017863
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
3. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
4. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urology].
Gumulec J; Penka M; Bezdĕk R; Czudek S; Stursa M; Wróbel M; Brejcha M; Klodová D; Sumná E; Králová S
Vnitr Lek; 2006 Mar; 52 Suppl 1():41-50. PubMed ID: 16637449
[TBL] [Abstract][Full Text] [Related]
6. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
[TBL] [Abstract][Full Text] [Related]
7. [Therapy and prevention of deep venous thrombosis and pulmonary embolism in gynecology and obstetrics].
Vucić N; Cala K; Rancić I; Pticar R
Acta Med Croatica; 2003; 57(2):123-30. PubMed ID: 12879692
[TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin for deep vein thrombosis in glioma patients.
Schmidt F; Faul C; Dichgans J; Weller M
J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
[TBL] [Abstract][Full Text] [Related]
10. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
11. [Enoxaparin for the prevention of post surgical pulmonary embolism].
Xia XY; Tan YL; Sun YW; Yan GD; Rong YX; Ren QH; Liu JY; Xu XZ; Shan GP; Jin L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Nov; 23(11):661-4. PubMed ID: 22093311
[TBL] [Abstract][Full Text] [Related]
12. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH).
Holzheimer RG
Eur J Med Res; 2004 Mar; 9(3):150-70. PubMed ID: 15096326
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
DeLoughery TG
Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
[TBL] [Abstract][Full Text] [Related]
15. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
[TBL] [Abstract][Full Text] [Related]
16. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage.
Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H
Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711
[TBL] [Abstract][Full Text] [Related]
17. Advances in DVT prophylaxis and management in major orthopaedic surgery.
Hardwick ME; Colwell CW
Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
[TBL] [Abstract][Full Text] [Related]
18. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
Tapson VF; Hull RD
Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
[TBL] [Abstract][Full Text] [Related]
19. The rationale for long-term prophylaxis of venous thromboembolism.
Agnelli G; Mancini GB; Biagini D
Orthopedics; 2000 Jun; 23(6 Suppl):s643-6. PubMed ID: 10875429
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
